CLPT insider buys 1,608 shares at $10.15 under ESPP 鈥� Form 4

Q: How many CLPT shares did Jeremy L. Stigall purchase?

Stigall purchased 1,608 common shares.

Q: At what price were the ESPP shares acquired?

The shares were bought at $10.15, the ESPP鈥檚 15 % discount price.

Q: What is Stigall's total share ownership after the transaction?

Following the purchase, he directly owns 72,355 CLPT shares.

Q: Did the filing report any sale of ClearPoint Neuro shares?

No. The Form 4 shows only an acquisition; there were no dispositions.

Q: Why is the purchase price discounted under the ESPP?

The ESPP allows employees to buy shares at 85 % of the lower of the market price on the first or last day of the purchase period.

[Form 4] Robinhood Markets, Inc. Insider Trading Activity

Filing Impact

(High)

Filing Sentiment

(Very Negative)

Form Type

Rhea-AI Filing Summary

Form 4 insider activity 鈥� ClearPoint Neuro, Inc. (CLPT)

Chief Business Officer Jeremy L. Stigall purchased 1,608 shares of ClearPoint Neuro common stock on 06/30/2025 through the company鈥檚 Employee Stock Purchase Plan (ESPP). The acquisition price was $10.15, reflecting the ESPP鈥檚 15 % discount to the lower of the market prices on the first or last day of the six-month purchase period (01/01/2025-06/30/2025). After the transaction, Stigall directly owns 72,355 CLPT shares.

No shares were sold and no derivative securities were involved. While the purchase is modest in size, insider buying鈥攅specially by a senior officer鈥攖ends to be interpreted as a sign of management鈥檚 confidence in the company鈥檚 prospects, albeit with limited immediate financial impact.

Positive

Insider purchase: Chief Business Officer acquired 1,608 shares, boosting direct ownership to 72,355 and signaling incremental management confidence.

Negative

None.

Insights

TL;DR: Small ESPP buy; positive signal but immaterial to fundamentals.

Stigall鈥檚 1,608-share purchase marginally increases his stake, taking advantage of the standard 15 % ESPP discount. The filing shows no sales or option exercises, implying a net commitment of capital. Although insider buying is directionally constructive鈥攅specially from a C-suite executive鈥攖he dollar value and share count are too small to alter valuation models or liquidity. The event is best viewed as a mild vote of confidence rather than a catalyst.

07/02/2025 - 05:11 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Warnick Jason

(Last)

(First)

(Middle)

C/O ROBINHOOD MARKETS, INC.

85 WILLOW ROAD

(Street)

MENLO PARK

94025

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Robinhood Markets, Inc. [ HOOD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	06/30/2025		M		175,000	A	$5.93	773,797	D
Class A Common Stock	06/30/2025		S		175,000⁽¹⁾	D	$90.087⁽²⁾	598,797	D
Class A Common Stock	07/01/2025		M		19,290	A	⁽³⁾	618,087	D
Class A Common Stock	07/01/2025		F		7,829⁽⁴⁾	D	$93.63	610,258	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (right to buy)	$5.93	06/30/2025		M			175,000	⁽⁵⁾	12/14/2028	Class A Common Stock	175,000	$0	375,000	D
Restricted Stock Units	⁽³⁾	07/01/2025		M			19,290	⁽⁶⁾	⁽⁶⁾	Class A Common Stock	19,290	$0	38,580	D

Explanation of Responses:

1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2025.

2. This transaction was executed in multiple trades during the day at prices ranging from $90.00 to $90.28. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide to the SEC staff, the Issuer, or any security holder of the Issuer, upon request, full information regarding the number of shares and prices at which the trades were made.

3. Restricted stock units ("RSUs") convert into Class A Common Stock on a one-for-one basis upon vesting and settlement.

4. Represents shares withheld by Robinhood Markets, Inc. ("Robinhood") to satisfy tax withholding obligations in connection with the vesting and settlement of 19,290 RSUs and does not represent a sale by the Reporting Person.

5. On December 15, 2018, the Reporting Person was granted an option to purchase 700,000 shares of Common Stock under Robinhood's Amended and Restated 2013 Stock Plan, which option was amended and restated on January 13, 2020. This option vested and became exercisable as to one-fourth (1/4) of those shares on December 4, 2019, with the remainder scheduled to vest and become exercisable in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service with Robinhood through the applicable vesting date and subject to accelerated vesting in certain circumstances.

6. On March 24, 2022, the Reporting Person was granted 77,160 RSUs under Robinhood's 2021 Omnibus Incentive Plan. One-fourth (1/4) of these RSUs vested on April 1, 2025, with the remainder scheduled to vest in three (3) equal quarterly installments thereafter, in each case subject to the Reporting Person's continued service with Robinhood through the applicable vesting date and subject to accelerated vesting in certain circumstances.

Remarks:

Warnick POA

	/s/ Lucas Moskowitz, attorney-in-fact for Jason Warnick	07/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What did ClearPoint Neuro's Form 4 filed on 07/02/2025 report?

It disclosed that Chief Business Officer Jeremy L. Stigall bought 1,608 CLPT shares on 06/30/2025 through the ESPP.

How many CLPT shares did Jeremy L. Stigall purchase?

Stigall purchased 1,608 common shares.

At what price were the ESPP shares acquired?

The shares were bought at $10.15, the ESPP鈥檚 15 % discount price.

What is Stigall's total share ownership after the transaction?

Following the purchase, he directly owns 72,355 CLPT shares.

Did the filing report any sale of ClearPoint Neuro shares?

No. The Form 4 shows only an acquisition; there were no dispositions.

Why is the purchase price discounted under the ESPP?

The ESPP allows employees to buy shares at 85 % of the lower of the market price on the first or last day of the purchase period.

AG真人官方

[Form 4] Robinhood Markets, Inc. Insider Trading Activity

Insights

FAQ

What did ClearPoint Neuro's Form 4 filed on 07/02/2025 report?

How many CLPT shares did Jeremy L. Stigall purchase?

At what price were the ESPP shares acquired?

What is Stigall's total share ownership after the transaction?

Did the filing report any sale of ClearPoint Neuro shares?

Why is the purchase price discounted under the ESPP?

NASDAQ:HOOD

HOOD Rankings

HOOD Latest News

HOOD Latest SEC Filings

HOOD Stock Data

AG真人官方

Trending News

[Form 4] Robinhood Markets, Inc. Insider Trading Activity

Insights

Equity Analyst neutral

FAQ

What did ClearPoint Neuro's Form 4 filed on 07/02/2025 report?

How many CLPT shares did Jeremy L. Stigall purchase?

At what price were the ESPP shares acquired?

What is Stigall's total share ownership after the transaction?

Did the filing report any sale of ClearPoint Neuro shares?

Why is the purchase price discounted under the ESPP?

NASDAQ:HOOD

HOOD Rankings

HOOD Latest News

HOOD Latest SEC Filings

HOOD Stock Data